SCHEMBL7230982

SCHEMBL7230982

N#Cc1cccc(-n2cccc2C(=O)O)c1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.51
PKM P14618 1/20 0.45
POLB P06746 3/20 0.44
APEX1 P27695 3/20 0.44
TDP1 Q9NUW8 3/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
DRD2 P14416 1/20 0.43
DRD3 P35462 1/20 0.43
XDH P47989 1/20 0.42
SLC22A12 Q96S37 1/20 0.42
CCR2 P41597 1/20 0.41
NSD2 O96028 1/20 0.41
HTT P42858 1/20 0.40
RECQL P46063 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
F11 P03951 1/20 0.40
ALOX5 P09917 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4787559 0.77 POLB (0.61) NOTUMPKMPOLBAPEX1TDP1
SCHEMBL27696672 0.76 COMT (0.53) PKMPOLBAPEX1TDP1L3MBTL1
SCHEMBL1418950 0.75 ATM (0.57) POLBAPEX1TDP1L3MBTL1DRD2
SCHEMBL16812366 0.74 NSD2 (0.47) NOTUMDRD2DRD3XDHNSD2
SCHEMBL25395450 0.74 CCR2 (0.55) L3MBTL1CCR2
SCHEMBL4538950 0.74 POLB (0.43) PKMPOLBAPEX1TDP1L3MBTL1
SCHEMBL6840228 0.74 ROCK2 (0.53) NOTUMPOLBAPEX1TDP1L3MBTL1
SCHEMBL1680141 0.73 F10 (0.53) NOTUMKMT2AF11
SCHEMBL24977670 0.72 GRM5 (0.53) NOTUMDRD2DRD3MEN1KMT2A
SCHEMBL25778555 0.72 L3MBTL1 (0.44) PKMPOLBAPEX1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6548512-B1 Pyrazole derivatives such as 1-(3-amidinophenyl)-3-methyl-2-((5-(2'-aminosulfonylphenyl-1-yl)pyrimidin-2 -yl)aminocarbonyl)pyrazole; treating thromboembolic disorders BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-04-15 US disclosed
CN-1246847-A Nitrogen containing heteroaromatics as factor Xa inhibitors DU PONT MERCK PHARMA (US) 2000-03-08 CN disclosed
US-6020357-A CARDIOVASCULAR DISORDERS; ANTCOAGULANTS DUPONT PHARMACEUTICALS COMPANY (US) 2000-02-01 US disclosed
EP-0946508-A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-10-06 EP disclosed
WO-1998028269-A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed